Candriam SCA’s Curis CRIS Stock Holding History

Candriam SCA’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-488	Closed	-$464K	–	790
2022 Q1	$464K	Sell	488 -9,649	-95%	-$12.3M	﹤0.01%	745
2021 Q4	$19.3M	Buy	10,137 +2,581	+34%	+$6.14M	0.12%	182
2021 Q3	$24.3M	Buy	7,556 +1,356	+22%	+$4.23M	0.17%	142
2021 Q2	$20M	Buy	+6,200	New	+$28M	0.14%	175
2021 Q1	–	Hold	0	–	–	–	792
2018 Q4	–	Sell	-400	Closed	-$285K	–	820
2018 Q3	$285K	Hold	400	–	–	﹤0.01%	758
2018 Q2	$277K	Hold	400	–	–	﹤0.01%	743
2018 Q1	$523K	Buy	+400	New	+$524K	0.01%	671

Other funds holding CRIS

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Candriam SCA's CRIS Position: Q2 2022 in Review

Candriam SCA sold out of Curis (CRIS) in Q2 2022, closing a stake of 488 shares — an estimated $464K sold.

Candriam SCA first reported a position in CRIS in Q1 2018 and held it in 7 quarters. The position peaked at $24.3M in Q3 2021. 86 funds tracked by Wall St. Rank hold CRIS as of Q2 2022.

Candriam SCA reported no remaining Curis position as of Q2 2022 after selling out during the quarter.
Candriam SCA sold 488 Curis shares in Q2 2022, an estimated $464K.
Candriam SCA first reported a position in Curis in Q1 2018 and held it in 7 quarters.
Candriam SCA's Curis position peaked at $24.3M in Q3 2021.
86 funds tracked by Wall St. Rank held Curis as of Q2 2022.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.